Viewing Study NCT01000506

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 2:40 PM
Ignite Modification Date: 2026-01-20 @ 2:16 PM
Study NCT ID: NCT01000506
Status: COMPLETED
Last Update Posted: 2018-01-24
First Post: 2009-10-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose-ranging View
None Safety View
None Pharmacodynamics View
None eosinophils View
None SB-240563 View
None Efficacy View
None Severe refractory asthma View
None mepolizumab View
None Placebo View